Modeling Prostate Specific Antigen Kinetics in Patients on Active Surveillance
BERKELEY, CA (UroToday.com) - Active surveillance (AS) is gaining popularity in the management of prostate cancer. In the October 2006 issue of the Journal of Urology, Dr. Zhang and associates from The University of Toronto report an active surveillance model that differentiates between low and high risk patients over time. This facilitates determining which patients should shift from active surveillance to active treatment.

Login to read more...

Written by Christopher P. Evans, MD, a Contributing Editor with UroToday.

Content on UroToday and UroToday International Journal is copyrighted and can be used for personal, noncommercial use only. You can order presentation-ready copies for distribution to your colleagues, clients or customers by emailing UroToday at commercialreprints@urotoday.com. Request a reprint quote of this article now, please include the title of the article and number or copies requested.

UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810 UroToday International Journal Correspondence About The Editors | About Us | Contact Us | Report an Inaccuracy | Sponsorship Opportunities | Terms of Use Privacy Policy | © 2010 Digital Science Press, Inc ® All Rights Reserved